Rockville, MD - Simvastatin (Zocor, Merck/Schering-Plough), used at the highest approved dose of 80 mg, is associated with an increased risk of myopathy, including rhabdomyolysis, according to the US ...
NEW YORK (Reuters) - A large study suggests that lowered levels of "bad" LDL cholesterol reduce risk of heart attacks and strokes in high-risk patients, but the trial dashed long-standing hopes that ...
FDA review finds increased risk of muscle damage, kidney failure. June 9, 2011 — -- The U.S. Food and Drug Administration has recommended limiting high doses of a widely prescribed ...
The cholesterol lowering drug is Zocor, also known as simvastatin. The FDA is warning doctors and patients to limit the use of the highest dose of the generic and Zocor brand versions. There is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback